je.st
news
Swiss pharma Novartis ups full-year sales outlook
2013-10-22 12:03:03| Biotech - Topix.net
Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan even though it said negative currency trends contributed to a 6 percent drop in its third-quarter net profit.
Tags: sales
ups
outlook
swiss
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||